| # | Side effect | Count |
|---|---|---|
| 0 | INJECTION SITE PAIN | 682 |
| 1 | PRODUCT DOSE OMISSION ISSUE | 670 |
| 2 | VIRAL LOAD INCREASED | 465 |
| 3 | VIROLOGIC FAILURE | 445 |
| 4 | PATHOGEN RESISTANCE | 352 |
| 5 | PAIN | 321 |
| 6 | OFF LABEL USE | 306 |
| 7 | PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT | 272 |
| 8 | VIRAL MUTATION IDENTIFIED | 244 |
| 9 | BLOOD HIV RNA INCREASED | 223 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | HLA-B*5701 ASSAY POSITIVE | 2 | 0.4000 |
| 1 | PROCTITIS CHLAMYDIAL | 4 | 0.3636 |
| 2 | PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT | 272 | 0.3112 |
| 3 | LYMPHOMA AIDS RELATED | 2 | 0.2500 |
| 4 | PERINATAL HIV INFECTION | 3 | 0.2143 |
| 5 | BLOOD HIV RNA BELOW ASSAY LIMIT | 3 | 0.2000 |
| 6 | JANEWAY LESION | 2 | 0.1818 |
| 7 | GALLBLADDER AGENESIS | 2 | 0.1818 |
| 8 | CONGENITAL CYTOMEGALOVIRUS INFECTION | 27 | 0.1588 |
| 9 | FLOPPY EYELID SYNDROME | 5 | 0.1429 |